Cardiac resynchronization and implantable defibrillators in adults with congenital heart disease

Area of Science:

• Cardiology
• Electrophysiology
• Adult Congenital Heart Disease

Background:

• Cardiac resynchronization therapy (CRT) and implantable cardioverter defibrillators (ICDs) are established treatments for heart failure in adults.
• Their efficacy and indications in adults with congenital heart disease (ACHD) are less defined due to limited large-scale prospective studies.

Purpose of the Study:

• To review the current evidence on the use of CRT and ICDs in the ACHD population.
• To highlight the role of these devices in select ACHD patients and the importance of individualized treatment decisions.

Main Methods:

• Review of multiple retrospective studies evaluating CRT and ICDs in ACHD patients.
• Synthesis of existing evidence to assess device efficacy and patient selection criteria.

Main Results:

• Retrospective studies indicate that CRT and ICDs are effective in improving outcomes for select ACHD patients.
• These devices demonstrate a role in managing heart failure and preventing sudden cardiac death in this population.

Conclusions:

• CRT and ICDs can be beneficial for select adults with congenital heart disease.
• A careful balance of risks and benefits, considering the heterogeneity of ACHD, is crucial for patient-specific application of these therapies.